OUR SCIENCE & TECHNOLOGY

Immunotherapies have emerged as one of the most-promising classes to treat patients with cancer. Our drug discovery efforts focus on addressing immune-oncologic targets that are implicated in the growth, resistance, recurrence, and metastasis of cancer. This approach is now focused on the mobilization of both adaptive and innate immunity, including immuno-oncology (IO) therapeutics, connecting bi-specific antibodies, and adoptive T cell and NK cell therapies. By addressing the fundamental biology underlying cancer’s evasion and metastasis, our novel therapeutic candidates are intended to improve patient quality of life and lead to more durable survival.

HOME > Terms of Use
Terms of Use
Terms of Use